Utilization and Cost of Supportive Care Among Patients Receiving Nab-Paclitaxel + Gemcitabine Versus Folfirinox for Metatstatic Pancreatic Cancer

Title
Utilization and Cost of Supportive Care Among Patients Receiving Nab-Paclitaxel + Gemcitabine Versus Folfirinox for Metatstatic Pancreatic Cancer
Authors
Keywords
-
Journal
VALUE IN HEALTH
Volume 19, Issue 3, Pages A143
Publisher
Elsevier BV
Online
2016-05-23
DOI
10.1016/j.jval.2016.03.1555

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search